Inadequacy the Health System in Serbia and Corrupt Institutions
Mat Soc Med. 2012; 24(4): 262-267
Rapid changes in the health system require a new trained professionals who fully understand the processes of health and organizational problems and have the knowledge and skills that enable them to manage health care services. Health services to their largely rests on a system of solidarity and “socialism”, and only partly on market principle, and more than in other sectors of the economy requires individuals who are able to bridge that gap. Realize savings in the system that one side is not profitable, on the other hand is able to swallow a huge media arts is that simply needs to learn–just relying on common sense and intuition that no longer helps. The increase in costs. Advances in medicine and technology, and discovery of new drugs, namely, the almost daily increase the costs of diagnosis and treatment. Advances in medicine prolongs life expectancy by increasing the number of patients, especially those with chronic diseases, the biggest consumer of drugs and frequent guests hospital.
1. Dickov V, Dickov A, Milicevic B. FREEDOM FROM DISEASE–Health protection system in Serbia–management approach. International Journal,Total Quality Management & Excellence. 2010; 38(2): 119-126.
2. Dickov V, Nerandjic B, Perovic V. Ekonomika moderna. Novi Sad: Stilos FTN, 2010. p. 9-23.
3. Baxandall P. Postcommunist Unemployment Politics: Historical Legacies and the Curious Acceptance of Job Loss. In: Grzegorz Ekiert and Stephen B. Hanson (eds). Capitalism and Democracy in Central and Eastern Europe. Cambridge University Press; 2002. p248-289.
4. Dickov V. Pharmaceutical Market Is Directly Linked To TheHealthcare. 2011.
5. System In Some Countries. Journal of Medical and Pharmaceutical Sciences. 2011; 1(2): 15-22.
6. Berglund SE, Joachim FA. The Challenge of History in Central and Eastern Europe. In: Sten Berglund, J. Ekman, and Fr. H. Aarebrot (eds.), The Handbook of Political Change in Eastern Europe. Cheltenham: Edwar Elgar; 2004. 13-56.
7. Bieling HJ.Europäische Integration: Determinanten und Handlungsmöglichkeiten. In: Joachim Beerhorst et al. (ed.).Kritische Theorie im gesellschaftlichen Strukturwandel. Frankfurt a. M.: Edition Suhrkamp; 2004.
8. Ziltener P. The Economic Effects of the European Single Market Project: Projections, Simulations, and the Reality. Review of International Political Economy. 2004; 11(5): 953-979.
9. Riboud MC, Sanchez-Paramo, Silva-Jauregui C. Does Eurosclerosis Matter? In: Institutional Reform and Labor Market Performance in Central and Eastern European Countries. In Funck B. and L. Pizzati, (eds.). Labor, Employment and Social Policies in the EU Enlargement Process. Washington DC: World Bank; 2002.
10. Donaldson R, Dejvis A. Business Ethics? Yes, But What Can it Do from the Bottom Line? Management Decision. 1990; 4: 34-49
11. Carroll A. Principles of Business Ethics: Their Role in Decision Making and in Initial Consensus. Management Decision. 1990: 28(8): 21-23
12. Dickov V, Kuzman B, Tomic S. NEW PHARMACEUTICAL PRODUCT DEVELOPMENT. International Journal of Novel Drug Delivery Technology) IJNDDT. 2011; 1(1): 47-62
13. Deacon B . Globalization and Social Policy. Geneva, UNRISD Occasional Paper. 2000; (5): 78-80.
14. Hegel GWF. A Szellem fenomenologiaja. Előszó. Lectures on Aesthetics. Budapest: Gondolat; 1979. p123-134.
15. Hirst P, Thompson G. The Problem of Globalization: International Economic Relations, National Economic Management and tge Formation of Trading Blocs, Economy and Society. 1992 (24): p. 99-101.
16. Dickov V, Kuzman B. Analyzing Pharmaceutical Industry.National Journal of Physiology, Pharmacy and Pharmacology. 2011; 1(1): 1-8
17. Sandier S et al. Health Care Systems in Transition. Edited by Sarah Thomson and Elias Mossialos, WHO Regional Office for Europe. 78-123.
18. General Medical Council, Good Medical Practice. Protecting Patients, Guiding Doctors. London; 2001. 24-28